The Regulatory Paradox: How FDA’s Application of Platform Technology Designation Is Stalling Rare Disease Breakthroughs.
When Kat Bryant Knudson was first diagnosed with limb girdle muscular dystrophy (LGMD), she was...
When Kat Bryant Knudson was first diagnosed with limb girdle muscular dystrophy (LGMD), she was...
The echo of a sinister houseboat lingers in the cinematic history of "Cape Fear," a...
Curiosity has observed small, isolated clusters of similar geometric shapes on Mars before, notably in...
The Women’s National Basketball Association (WNBA) is experiencing a renaissance, fueled by a constellation of...
Transferable rewards are the most potent currency in the travel ecosystem primarily because of their...
The past week has seen a dramatic acceleration of these overlapping tensions. Last weekend, Kyiv...
US prosecutors have officially dropped all charges against former Olympian David Hearn, who had been...
Ask any barber for a fade, and they’ll almost immediately get straight to work. Operative...
OpenAI CEO Sam Altman recently ignited a firestorm of online discussion with what he described...
The discourse surrounding the efficacy of nonpharmaceutical interventions (NPIs) during the COVID-19 pandemic remains one...